- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis4 p5 m: d' w- Y; i; m! T6 E
was to close its brain research facility in Basel, Switzerland,
4 F$ t/ ~7 w6 M+ Othe story noted that this move closely followed similar cuts' o. @6 b% f( M2 }2 p' P
by rival pharmaceutical firms. As a report from the European College
; V# n7 I- [6 @of Neuropsychopharmacology$ k6 {' V" T+ i! D N/ b
had warned a few months earlier, the# J5 q8 f: w6 v# o
abandonment of research into new psychiatric drugs by AstraZeneca,
3 X7 j! K/ m. f: p/ z) SGlaxoSmithKline
- s2 k, Z2 k5 q1 Fand others meant that “withdrawal of research
7 k2 h! d2 C5 H, F* U; ]( y: Iresources is a withdrawal of hope for patients and their families”.2 M; y8 |- k, [# ? n" \0 r7 E
5 }/ f& C+ G6 G& J. @" d n: X$ `* X5 e( P; D% J
回复有免费下载链接5 a7 b% { k( @3 l$ F
: d5 }' [% \ F& |2 q8 s |
-
总评分: 包包 + 20
查看全部评分
|